QP-Prostate
Prostate Cancer Diagnosis
CommercialActive
Key Facts
About Quibim
Quibim is a Valencia-based leader in the radiomics and quantitative imaging AI space, operating a secure, cloud-native platform (QP-Insights®) that harmonizes, manages, and analyzes large-scale imaging and multi-omics data. The company has a dual business model: it offers AI-powered diagnostic software (QP-Prostate, QP-Brain, QP-Liver) to healthcare providers and provides biomarker discovery and clinical trial analytics services to biopharma partners. With ISO 27001 certification and a focus on data security, Quibim leverages one of the world's largest de-identified imaging registries to build predictive models aimed at accelerating drug development and improving patient outcomes in precision medicine.
View full company profileTherapeutic Areas
Other Prostate Cancer Diagnosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Triopsy Biopsy System | Triopsy | Commercial |
| OmnEcoil Device | OmnEcoil Instruments | Development/Prototype |
| Promaxo MRI System for Prostate Biopsy | Promaxo | Approved |